Two Sigma Securities’s Alimera Sciences ALIM Stock Holding History

Two Sigma Securities’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,873	Closed	-$60.5K	–	3820
2024 Q2	$60.5K	Buy	+10,873	New	+$38.6K	﹤0.01%	2550
2018 Q4	–	Sell	-1,767	Closed	-$26K	–	2953
2018 Q3	$26K	Buy	+1,767	New	+$26.9K	﹤0.01%	2415
2018 Q2	–	Sell	-2,399	Closed	-$37K	–	3088
2018 Q1	$37K	Sell	2,399 -401	-14%	-$7.11K	﹤0.01%	2528
2017 Q4	$56K	Buy	2,800 +1,942	+226%	+$37.9K	﹤0.01%	1514
2017 Q3	$17K	Buy	+858	New	+$18.4K	﹤0.01%	840
2017 Q1	–	Sell	-1,546	Closed	-$25K	–	1158
2016 Q4	$25K	Buy	+1,546	New	+$28.3K	0.01%	643

Two Sigma Securities's ALIM Position: Q3 2024 in Review

Two Sigma Securities sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 10,873 shares — an estimated $60.5K sold.

Two Sigma Securities first reported a position in ALIM in Q4 2016 and held it in 6 quarters. The position peaked at $60.5K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Two Sigma Securities reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 10,873 Alimera Sciences shares in Q3 2024, an estimated $60.5K.
Two Sigma Securities first reported a position in Alimera Sciences in Q4 2016 and held it in 6 quarters.
Two Sigma Securities's Alimera Sciences position peaked at $60.5K in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.